The Latest Breaking News on Pharma

The U.S. Drug Enforcement Administration is closing two of its offices in China, a move that comes even as the agency struggles to disrupt the flow of precursor chemicals from the country that have fueled a fentanyl epidemic

The drugmaker said its injections were 89 percent more effective than its own Truvada

The healthcare sector is set for robust growth, driven by surging demand for quality treatments, a growing patient base, breakthroughs in biopharma, and supportive policies. Therefore, investors could consider undervalued pharmaceutical stocks like Merck & Co. (MRK), Pfizer (PFE), and Cigna (CI) with significant upside potential. Read more.

Nearly five years after COVID-19, a new analysis by The Associated Press shows that U.S. regulators are struggling to address a massive backlog of uninspected pharmaceutical plants

U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected during disruptions caused by COVID-19

Pinellas Suncoast Transit Authority in Florida takes proactive steps to address opioid crisis by training employees and installing Narcan kits at terminals.

The lifecycle of AMD's new (but still unannounced) GPU continues, and now we're seeing the low-end version move in shipping manifests.

With the rising prevalence of chronic diseases, increasing cell and gene therapies, and rising tech adoption in the biotech industry, the oncology market is booming. Amid this backdrop, investors could consider quality biotech stocks Pyxis Oncology (PYXS), Immatics (IMTX), and Jazz Pharmaceuticals (JAZZ), having significant upside potential. Continue reading.

Mother tells Maya Oppenheim she was forced into having a hysterectomy which meant she ‘car crashed into menopause’ at the age of 45